CCGB(SZ:300138)2025-07-09 09:45Current Period Performance Forecast The company expects significant year-over-year growth in net profit for H1 2025, with attributable net profit increasing by 102.33% to 132.38% Key Financial Performance Indicators | Indicator | 2025 H1 Forecast | 2024 H1 Actual | YoY Change | | :--- | :--- | :--- | :--- | | Operating Revenue | CNY 3.46 billion - CNY 3.76 billion | CNY 3.491 billion | -0.89% to 7.71% | | Net Profit Attributable to Shareholders | CNY 202 million - CNY 232 million | CNY 99.8 million | 102.33% to 132.38% | | Net Profit Attributable to Shareholders (Excluding Non-recurring Items) | CNY 174 million - CNY 204 million | CNY 80 million | 117.40% to 154.88% | Pre-Audit Status of Performance Forecast The performance forecast data is a preliminary estimate by the finance department and is currently unaudited - The data in this performance forecast has not been audited by a certified public accountant5 Explanation of Performance Changes H1 2025 performance growth is driven by the cottonseed business turnaround and increased gross profit from key botanical extract products - The primary reason for performance growth is the market recovery of the cottonseed business, achieving a year-over-year turnaround from loss to profit6 - Gross profit for botanical extract businesses, including capsanthin, capsicum oleoresin, and stevia, all achieved year-over-year growth6 - Non-recurring gains and losses for H1 2025 are estimated to be approximately CNY 28 million6 Other Relevant Information This performance forecast is a preliminary estimate, with final data in the 2025 semi-annual report, advising investors to note investment risks - This performance forecast is a preliminary estimate by the company's finance department, and the final data will be subject to the 2025 semi-annual report7 - Investors are advised to exercise caution in their decisions and be aware of investment risks7